News & Event

Register for news & events
News icon

March 2024

RevitalVision Post Crosslinking Surgery Study Won the Best ASCRS Scientific Poster Award

RevitalVision’s study on post crosslinking surgery patients won the best scientific poster award at ASCRS 2024, and was selected for a live presentation.

This prospective, controlled randomized study evaluated the efficacy of RevitalVision’s vision-training software- program in improving best corrected vision in stable keratoconus patients post crosslinking surgery, and showed remarkable clinical outcomes!

The results demonstrated significant improvement in vision, with a mean improvement of 2.5 VA lines, as well as improvements in contrast sensitivity function (CSF) among crosslinked keratoconus patients who received RevitalVision treatment.

We thank Prof. Lional Raj, Prof. David Heber and the rest of Dr.Agarwal’s Eye Hospital Research team for their awarded work!

Read the full abstract
News icon

Feb 2024

AECOS (American-European Congress of Ophthalmic Surgery)

RevitalVision’s CEO, Yair Yahav, participated in the 2024 AECOS innovation forum, which featured eight top industry innovations. The forum was moderated by Mr. William Link, PhD.

 

News icon

December 2023

RCT Results of RevitalVision Therapy in Congenital Nystagmus Patients – live presentation at AAPOS

Groundbreaking RCT Results evaluating the efficacy of RevitalVision Therapy in Congenital Nystagmus Patients will be presented at the upcoming AAPOS 2024 annual meeting.

The results provide new hope for Nystagmus patients lacking effective treatment to improve vision.

The results will be presented at AAPOS this year, by Dr. Idan Hecht, on Wednesday, April 10th, at 12:30 p.m. (CST)

News icon

April 2023

AAPOS 23 annual meeting- presenting poster with mid term study results

During the 48th annual meeting of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS 23), Dr. Sigal Zmujack’s presented the mid-term results of two new controlled randomized studies evaluating RevitalVision’s efficacy in improving vision in nystagmus and amblyopia patients aged 9-55, which both showed significant anti-suppression effects.

Download the poster
News icon

January 2023

Narayana Nethralaya Eye Foundation – What & how does my child see Conference

RevitalVision CEO Yair Yahav was a guest speaker at the Narayana Nethralaya Eye Foundation symposium on Amblyopia, Binocular Vision, Cortical Visual Impairment, and Low Vision.

He presented a scientific & clinical review on Optimizing Cortical Visual Functions with RevitalVision.

Watch the full presentation

News icon

January 2023

A new published study on RevitalVision treatment

This independent study, which was published in Vision Development and Rehabilitation: COVD’s Digital Journal, evaluated the efficacy of RevitalVision’s perceptual-based vision training program, in improving visual acuity in adult amblyopic individuals beyond occlusion.

Read the full publication (p.260)
1 2 3 5

CONTÁCTENOS

    Talshir Medical Technologies LTD
    Hama’ayan Street 2, Modi’in 7177871, Israel
    USA Phone: 1.800.361.8218 | Main Office: +972.77.212.3272

    info@revitalvision.com